Skip to main content

SGRX · Sangrix Inc.

Track SGRX — free
$0.44 -0.13 (-23.60%) At close · Nov 6
Market Cap
$1.59M
Shares
3.64M
Volume · Nov 6 1.2M Avg daily vol (55 sessions) 7M

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.44 Open$0.51 Day$0.30–0.54 52W close$0.38–93.90 Avg vol 30d12.0M Short int53K · 1.5% of shares · 1.0d Short vol28% DataJan 2020–Nov 2026

Latest documents

2026
Oct 30
Current report 6-K
Holders convert $3,300,000 of notes into 2,153,257 shares

Between September 30, 2026 and October 16, 2026, holders converted $3,300,000 of Sangrix Inc.’s senior secured convertible notes, plus $209,807 accrued interest, into 2,153,257 Class A ordinary shares at $1.63 per share.

Source passage
Between September 30, 2026 and October 16, 2026, the holders of the senior secured convertible notes of Sangrix Inc. (the “Company”) converted an aggregate principal amount of $3,300,000, together with accrued interest of $209,807, into an aggregate of 2,153,257 Class A ordinary shares of the Company, par value $0.0003 per share, at a conversion price of $1.63 per share. Open the document at this passage
Oct 23
Current report 6-K
Current report

Sangrix Inc. shareholders will vote on November 3, 2026 to approve a ten (10)-for-one (1) share consolidation, effective November 13, 2026, to help Class A Ordinary Shares meet Nasdaq’s US$1.00 minimum bid price.

Read from the first part of this long document
Oct 22
Current report 6-K
Current report

Sangrix Inc. issued 75,000 Class B Ordinary Shares to Jinghai Jiang on October 21, 2026 for $32,925.00 at $0.4390 per share, giving him 100% of its Class B ordinary shares and approximately 35% of total voting power.

All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$39,495
Trailing 12 months
Net income (TTM)
−$13.28M
Trailing 12 months
Revenue growth YoY
-98.6%
Year over year
Operating margin
-7,574.9%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+341.1%
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
1.5%
Latest settlement · 1.0 days to cover
View all 125 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Neutral Momentum Very Weak Sentiment Bearish Fundamentals Fair Quant / Vol Very High
Market backdrop VIX 25.6 · fear Equity put/call 0.59
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg −94%
below
Price vs 50-day avg −64%
below
RSI (14) 34
neutral
MACD trend Positive
52-week position 0%
near low
Volume (OBV) Bullish div.
accumulating
Momentum
relative strength
Very Weak
1-month return −41%
trailing
6-month return −95%
trailing
YTD return −99%
this year
Relative strength −94%
vs S&P · 6-mo
Sentiment
smart money
Bearish
Trend (MA cross) No cross
50d $1 › 200d $8 — 200d above 50d
Institutional flow Distributing
3 of 5 funds reported for Sep 30 · net -2.5K sh shares
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
1.45% of shares out · ▲ +241.4% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
5 holders — mid 3-yr range
Squeeze score 43
elevated · 0–100
Fundamentals
Fair
Revenue growth −99%
Y/Y
Gross margin 100%
expanding
EPS growth +17%
Y/Y
Free cash flow $-3.0M
Quant / Vol
risk profile
Very High
Volatility 158%
annualized · 1-yr
Max drawdown −100%
past year
ATR 54.2%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Neutral
3 · 2 · 2
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−94% Bearish
Price vs 50-day avg
−64% Bearish
RSI (14)
34 Neutral
MACD trend
Positive Bullish
52-week position
0% Bearish
Volume (OBV)
Bullish div. Bullish
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $1 › 200d $8 — 200d above 50d
Institutional flow Distributing
3 of 5 funds reported for Sep 30 · net -2.5K sh shares
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
1.45% of shares out · ▲ +241.4% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
5 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $0 Now $0 · 0% Range high $94
vs 200-day avg -94% vs 50-day avg -64%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Information Technology Services — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
SGRX
Sangrix Inc.
this stock
$1.59M — -98.6% — 1.5%
IBM
International Business Machines Corp
$231.55B -17.3% +7.6% 20.9 2.1%
ACN
Accenture plc
$174.28B -2.9% +6.5% 19.2 3.0%
INFY
Infosys Ltd
$50.63B -29.9% — — 2.6%
CTSH
Cognizant Technology Solutions Corp
$28.93B -22.0% +7.0% 11.8 6.6%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
4
% held
0.1%
Reported
3 of 5
Top holder
HRT FINANCIAL LP
Held Float
View
Short & Settlement
Short Interest Rising
Shares short
52.9K
Days to cover
1.0d
Change
+37.4K sh
View
Short Volume
Short vol %
28%
As of
Nov 6, 2026
Short Total
View
Fails to Deliver
FTD shares
150
Value
$227
As of
Sep 30, 2026
View
Off-Exchange
Off-exchange %
57.4%
Week of
Sep 28, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$39.5K
Net income (FY)
$-17.5M
EPS diluted
$-70.43
View
Filings
SEC Filings
Latest
6-K
Filed
Nov 5, 2026
This year
28
View
Exempt Offerings
Offering
$2.0M
Filed
Jun 12, 2024
View

Performance

5D 20D 120D MTD YTD
SGRX -40.6% -41.1% -94.7% -40.6% -99.2%
SPY -2.7% -5.6% -0.5% -2.7% +7.8%
vs SPY -37.9% -35.5% -94.3% -37.9% -107.0%
Key facts CIK 1735556 CUSIP G21621209 13F (30d) 2 filings 2 filers Visit website Investor relations